Prognostic Value of Estimated versus Measured Plasma Fibrinogen Level in Traumatized Critically Ill Patients

Document Type : Original papers

Authors

1 Associated professor of critical care medicine, Faculty of Medicine, Cairo University

2 Master degree of critical care medicine, Cairo University

3 Professor of Critical care, Faculty of medicine, Cairo University

4 Professor of Clinical Pathology, faculty of medicine, Cairo University

Abstract

Background: This prospective observational study aimed to evaluate the prognostic value of both measured and estimated plasma fibrinogen levels in predicting mortality and morbidity in critically ill trauma patients. Methods: A total of 80 severely injured trauma patients (Injury Severity Score [ISS] 3-5) were enrolled, along with 20 healthy controls for comparison. Fibrinogen levels were measured and estimated, and their correlation with clinical outcomes, including mortality, length of stay (LOS), and ICU duration, was analyzed.
Results:

A significant inverse correlation was observed between plasma fibrinogen levels and APACHE II scores (p = 0.0001).
Fibrinogen levels were significantly inversely correlated with ICU length of stay (p = 0.037).
A fibrinogen threshold of 5 mg/dl was found to predict survival with:

Sensitivity: 67%
Specificity: 78%
p-value: 0.007


A higher fibrinogen cutoff of 332 mg/dl was predictive of severe trauma (ISS 4 or 5), with an area under the curve (AUC) of 98, sensitivity of 100%, and specificity of 98%.
A lower cutoff value of 247 mg/dl demonstrated:

Sensitivity: 100%
Specificity: 75%


Base excess, hemoglobin, and Injury Severity Score (ISS) were incorporated into a statistical model for estimating log-transformed fibrinogen levels, yielding an R² of 79% and a correlation coefficient of 75% between estimated and measured log fibrinogen levels.
Lower fibrinogen levels were significantly associated with worse outcomes, including longer hospital stays. The estimation of fibrinogen levels in severe trauma cases is crucial for predicting survival and identifying patients who may benefit from targeted transfusion of coagulation factors.

Keywords

References

  1. Mosesson MW. Fibrinogen and fibrin structure and functions. Journal of Thrombosis and Haemostasis. 2005 Aug; 3(8):1894-904. 
  2. Gama S. Low fibrinogen levels: How to maximize accuracy when using an optically derived method. Journal of Applied Hematology. 2016 Oct 1; 7(4):148. 
  3. Schlimp CJ, Schöchl H. Fibrinogen Assays. In Trauma Induced Coagulopathy 2016 (pp. 227-235).
  4. Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low-or high-plasma-content massive transfusion protocol. American journal of clinical pathology. 2011 Sep 1; 136(3):364-70. 
  5. Hayakawa M, Gando S, Ono Y, Wada T, Yanagida Y, Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. In Seminars in thrombosis and hemostasis 2015 Feb (Vol. 41, No. 01, pp. 035-042).
  6. Winearls J, Campbell D, Hurn C, Furyk J, Ryan G, Trout M, et al. Fibrinogen in traumatic haemorrhage: a narrative review. Injury. 2017 Feb 1; 48(2):230-42. 
  7. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. British journal of anaesthesia. 2012 Oct 16; 109(6):851-63.  
  8. Schlimp CJ, Voelckel W, Inaba K, Maegele M, Ponschab M, Schöchl H. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Critical care. 2013 Aug; 17(4):R137.
  9. Cohen MJ, Kutcher M, Redick B, Nelson M, Call M, Knudson MM, et al. Clinical and mechanistic drivers of acute traumatic coagulopathy. The journal of trauma and acute care surgery. 2013 Jul; 75(101):S40. 
  10. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. Journal of Trauma and Acute Care Surgery. 2009 Jul 1; 67(1):202-9. 
  11. White NJ, Martin EJ, Brophy DF, Ward KR. Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation. Resuscitation. 2010 Jan 1; 81(1):111-6. 
  12. Hayakawa M. Dynamics of fibrinogen in acute phases of trauma. Journal of Intensive Care. 2017 Dec;5(1):3. 
  13. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis. 2007 Feb; 5(2):266-73. 
  14. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. Journal of Thrombosis and Haemostasis. 2012 Jul; 10 (7):1342-51. 
  15. Schöchl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, et al. FIBTEM provides early prediction of massive transfusion in trauma. Critical Care. 2011 Dec; 15(6):R265.  
  16. Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, El Attal R, et al. Prevalence and impact of abnormal ROTEM® assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’. British journal of anaesthesia. 2011 Jun 23; 107(3):378-87. 
  17. Inaba K, Karamanos E, Lustenberger T, Schöchl H, Shulman I, Nelson J, et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. Journal of the American College of Surgeons. 2013 Feb 1; 216(2):290-7. 
  18. Bouzat P, Ageron FX, Charbit J, Bobbia X, Deras P, Nugues JB, et al. Modelling the association between fibrinogen concentration on admission and mortality in patients with massive transfusion after severe trauma: an analysis of a large regional database. Scandinavian journal of trauma, resuscitation and emergency medicine. 2018 Dec;26(1):55.
  19. Schlump CJ, Cadmore J, Solomon C, Redl H, Schöchl H. The effect of fibrinogen concentrates and factor XIII on Thromboelastometric in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfusion. 2013 Oct;11(4):510. 

Files

Share

How to cite

Statistics